Rosa De Miguel, María de Lagarde Sebastian, José Luis Blanco Arévalo, Adriana Pinto-Martinez, Rocío Montejano, Angela Gutiérrez Liarte, Roser Navarro-Soler, Esperanza Cañas-Ruano, Alexis Inciarte, Luz Martin-Carbonero, et al. (2025). Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons with Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicentre, Phase IIA Clinical Trial . Clinical Infectious Diseases.

Montserrat Laguno, Elisa de Lazzari, Leire Berrocal, Alexy Inciarte, Maria Mart&#237;nez‐Rebollar, Lorena de la Mora, Berta Torres, Ana Gonzalez‐Cord&#243;n, Ivan Chivite, Alberto Foncillas, et al. (2024). Burden of liver steatosis and liver fibrosis in a large cohort of people living with <scp>HIV</scp> . HIV Medicine.

Emilio Felipe Huaier Arriazu, Alexy Inciarte (2024). El riesgo de transmisión sexual del VIH es casi nulo cuando la carga viral es menor de 1.000 copias/mL . Evidencia - actualizacion en la práctica ambulatoria.

Stefan Esser, Alexy Inciarte, Itzchak Levy, Antonella D&#39;Arminio Monforte, John S. Lambert, Berend van Welzen, Katsuji Teruya, Marta Boffito, Chun-Eng Liu, Ozlem A. Aydın, et al. (2024). Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 year . Future Microbiology.

Ainoa Ugarte, Lorena De La Mora, Elisa De Lazzari, Iv&#225;n Chivite, Emma Fern&#225;ndez, Alexy Inciarte, Montserrat Laguno, Juan Ambrosioni, Estela Solbes, Leire Berrocal, et al. (2024). Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study . Journal of Antimicrobial Chemotherapy.

Alexy Inciarte, Elizabeth Zamora-Clemente (2024). Larva migratoria, un diagnóstico poco común en viajeros . Revista Española de Casos Clínicos en Medicina Interna.

Alexy Inciarte, Lorena de la Mora, Emilio Huaier-Arriazu, Berta Torres, Silvia Ca&#241;izares, Elizabeth Zamora, Montserrat Laguno, Ana Gonzalez-Cord&#243;n, Alberto Foncillas, Ivan Chivite, et al. (2024). Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations . Infectious Diseases and Therapy.

Daniel K Nomah, Yesika D&#237;az, Andreu Bruguera, Sergio Moreno-Forn&#233;s, Jordi Aceiton, Juliana Reyes-Urue&#241;a, Josep M Llibre, Vicen&#231; Falc&#243;, Arkaitz Imaz, Francisco Javier Fanjul, et al. (2024). Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score–Matched Analysis . Open Forum Infectious Diseases.

Stefan Esser, Jason Brunetta, Alexy Inciarte, Itzchak Levy, Antonella D&#39;Arminio Monforte, John S. Lambert, Berend van Welzen, Katsuji Teruya, Marta Boffito, Chun‐Eng Liu, et al. (2023). Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with <scp>HIV</scp>: Real‐world insights from <scp>BICSTaR</scp> cohorts . HIV Medicine.

Beatriz Borjabad, Alexy Inciarte, Ivan Chivite, Ana Gonzalez-Cordon, Mar Mosquera, Carmen Hurtado, Cristina Rovira, Tania Gonzalez, Abiu Sempere, Berta Torres, et al. (2023). Efficacy and safety of raltegravir plus lamivudine maintenance therapy . Journal of Antimicrobial Chemotherapy.

Alba Rocabert, Beatriz Borjabad, Leire Berrocal, Jordi Blanch, Alexy Inciarte, Ivan Chivite, Ana Gonzalez-Cordon, Berta Torres, Juan Ambrosioni, Maria Martinez-Rebollar, et al. (2023). Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting . Journal of Antimicrobial Chemotherapy.

Adri&#225;n Mart&#237;nez-Serra, Elisa De Lazzari, Leire Berrocal, Alberto Foncillas, Lorena De La Mora, Alexy Inciarte, Iv&#225;n Chivite, Ana Gonz&#225;lez-Cord&#243;n, Mar&#237;a Mart&#237;nez-Rebollar, Berta Torres, et al.(2023). Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study . Journal of Antimicrobial Chemotherapy. 78. (8). p. 1955--1962. Oxford University Press ({OUP})

Alexy Inciarte, Ainoa Ugarte, Mar&#237;a Mart&#237;nez-Rebollar, Berta Torres, Emma Fern&#225;ndez, Leire Berrocal, Montserrat Laguno, Lorena De la Mora, Elisa De Lazzari, Pilar Callau, et al. (2023). Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP) . Open Forum Infectious Diseases.

Lorena De La Mora, Cristina Pitart, Laura Morata, Ainoa Ugarte, Mar&#237;a Martinez-Rebollar, Elisa De Lazzari, Andrea Vergara, Jordi Bosch, Ignasi Roca, Maria Piquet, et al.(2023). Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study . Infectious Diseases and Therapy. Springer Science and Business Media {LLC}

Adri&#225;n Mart&#237;nez-Serra, Elisa De Lazzari, Leire Berrocal, Alberto Foncillas, Lorena De La Mora, Alexy Inciarte, Iv&#225;n Chivite, Ana Gonz&#225;lez-Cord&#243;n, Mar&#237;a Mart&#237;nez-Rebollar, Berta Torres, et al.(2023). Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study . Journal of Antimicrobial Chemotherapy. Oxford University Press ({OUP})

Tommaso-Francesco Aiello, Pedro Puerta-Alcalde, Mariana Chumbita, Carlos Lopera, Patricia Monz&#243;, Albert Cortes, Francesc Fern&#225;ndez-Avil&#233;s, Mar&#237;a Su&#225;rez-Lled&#243;, Juan Correa, Valent&#237;n Ortiz-Maldonado, et al.(2023). Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals . Journal of Antimicrobial Chemotherapy. Oxford University Press ({OUP})

Elisa de Lazzari, Leire Berrocal, Emma Fern&#225;ndez, Montserrat Laguno, Iv&#225;n Chivite, Berta Torres, Ana Gonz&#225;lez-Cord&#243;n, Lorena de la Mora, Juan Ambrosioni, Alexy Iniciarte, et al. (2023). Perception of quality of care using patient reported experience measures (PREMs) in a cohort of adults with HIV: A cross-sectional study . Medicine.

Sara Toyos, Leire Berrocal, Ana Gonz&#225;lez-Cord&#243;n, Alexy Inciarte, Lorena de la Mora, Mar&#237;a Mart&#237;nez-Rebollar, Montserrat Laguno, Emma Fern&#225;ndez, Juan Ambrosioni, Iv&#225;n Chivite, et al.(2023). Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020 . Eurosurveillance. 28. (10). European Centre for Disease Control and Prevention ({ECDC})

Rafael Perello, Aelajandra Losada, Jiwei Chen Qin, August Supervia, Emilio Salgado, Alex Smithson, Marc Xipell, Alexis Inciarte, Gabriel Vallecillo(2023). Amphetamine‐related intoxications in people living with <scp>HIV</scp> : An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020 . HIV Medicine. 24. (3). p. 260--266. Wiley

Rafael Perello, Aelajandra Losada, Jiwei Chen Qin, August Supervia, Emilio Salgado, Alex Smithson, Marc Xipell, Alexis Inciarte, Gabriel Vallecillo(2023). Amphetamine‐related intoxications in people living with <scp>HIV</scp> : An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020 . HIV Medicine. 24. (3). p. 260--266. Wiley

Ainoa Ugarte, Lorena de la Mora, David Garc&#237;a, Mar&#237;a Mart&#237;nez-Rebollar, Elisa de Lazzari, Berta Torres, Alexy Inciarte, Juan Ambrosioni, Iv&#225;n Chivite, Estela Solbes, et al.(2023). Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience . Infectious Diseases and Therapy. 12. (2). p. 425--442. Springer Science and Business Media {LLC}

Lorena Usero, Lorna Leal, Carmen Elena G&#243;mez, Laia Miralles, Elena Aurrecoechea, Ignasi Esteban, Berta Torres, Alexy Inciarte, Beatriz Perdiguero, Mariano Esteban, et al.(2023). The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses . Vaccines. 11. (2). p. 286. {MDPI} {AG}

Montserrat Laguno, Ainoa Ugarte, Mar&#237;a Martinez-Rebollar, Yeray Sobrino, Guillermo Font, Elisa de Lazzari, Lorena de la Mora, Berta Torres, Iv&#225;n Chivite, Josep Riera, et al.(2023). PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement . Enfermedades infecciosas y microbiologia clinica (English ed.). 41. (1). p. 24--28. Elsevier {BV}

Gabriel Vallecillo and Alejandra Losada and Alexy Inciarte and Chen Jiwei and Albert Monterde and Emilio Salgado and Adriana Laura Doi and Esther Monclus and Rafael Perell{\'{o}}(2022). Increasing emergency department admissions for chemsex-related intoxications in Barcelona, Spain, among people living with HIV: an observational study from 2018 to 2020 . BMC Public Health. 22. (1). Springer Science and Business Media {LLC}

Lorena De La Mora, Mar&#237;a J. Nebot, Maria Martinez-Rebollar, Elisa De Lazzari, Montserrat Tuset, Montserrat Laguno, Juan Ambrosioni, Laia Miquel, Jordi Blanch, Ainoa Ugarte, et al.(2022). Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study . Infectious Diseases and Therapy. 11. (6). p. 2111--2124. Springer Science and Business Media {LLC}

Perello, R., Losada, A., Chen, J., Supervia, A., Salgado, E., Smithson, A., Xipell, M., Inciarte, A., & Vallecillo, G. (2022). Amphetamine-related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020. HIV medicine, 10.1111/hiv.13365. Advance online publication. https://doi.org/10.1111/hiv.13365 .

(2022). PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement . Enfermedades infecciosas y microbiologia clinica (English ed.).

Lorena De La Mora and Ainoa Ugarte and Maria Mart{\'{\i}}nez-Rebollar and Elisa De Lazzari and David Garc{\'{\i}}a-Hern{\'{a}}ndez and Guillermo Font and Nicol{\'{a}}s De Loredo and Estela Solbes and Laia Miquel and Jordi Blanch and Berta Torres and Josep Riera and Iv{\'{a}}n Chivite and Juan Ambrosioni and Alexy Inciarte and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Esteban Mart{\'{\i}}nez and Jos{\'{e}} Luis Blanco and Josep Mallolas and Montserrat Laguno(2022). Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life—Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain . AIDS and Behavior. Springer Science and Business Media {LLC}

Daniel K. Nomah and Juliana Reyes-Urue{\~{n}}a and Yesika D{\'{\i}}az and Sergio Moreno and Jordi Aceiton and Andreu Bruguera and Rosa M. Vivanco-Hidalgo and Jordi Casabona and Pere Domingo and Jordi Navarro and Arkaitz Imaz and Elisabet Deig and Gemma Navarro and Josep M. Llibre and Jose M. Miro and Esteve Muntada and Anna Esteve and Francisco Fanjul and Vicen{\c{c}} Falc{\'{o}} and Hernando Knobel and Josep Mallolas and Juan Tiraboschi and Adri{\`{a}} Curran and Joaqu{\'{\i}}n Burgos and Boris Revollo and Maria Gracia and Maria del Mar Gutierrez and Javier Murillas and Francisco Homar and Jose V. Fern{\'{a}}ndez-Montero and Eva Gonz{\'{a}}lez and Joaquim Peraire and Llu{\'{\i}}s Force and Elena Leon and Miquel Hortos and Ingrid Vilar{\'{o}} and Amat Orti and David Dalmau and {\`{A}}ngels Jaen and Elisa De Lazzari and Leire Berrocal and Luc{\'{\i}}a Rodr{\'{\i}}guez and Freya Gargoulas and Toni Vanrell and Jose Carlos and Josep Vil{\`{a}} and Marina Mart{\'{\i}}nez and Bibiana Morell and Maribel Tamayo and Jorge Palacio and Juan Ambrosioni and Montse Laguno and Mar{\'{\i}}a Mart{\'{\i}}nez-Rebollar and Jos{\'{e}} L. Blanco and Felipe Garcia and Berta Torres and Lorena de la Mora and Alexy Inciarte and Ainoa Ugarte and Iv{\'{a}}n Chivite and Ana Gonz{\'{a}}lez-Cordon and Lorna Leal and Antoni Jou and Eug{\`{e}}nia Negredo and Maria Saumoy and Ana Silva and Sofia Sc{\'{e}}vola and Paula Suanzes and Patricia Alvarez and Isabel Mur and Melchor Riera Jaume and Mercedes Garc{\'{\i}}a-Gasalla and Maria {\`{A}}. Ribas and Antoni A. Campins and Mar{\'{\i}}a Pe{\~{n}}aranda and Mar{\'{\i}}a L. Martin and Helem Haydee and S{\`{o}}nia Calzado and Manel Cervantes and Marta Navarro and Antoni Payeras and Carmen Cifuentes and Aroa Villoslada and Patr{\'{\i}}cia Sorn{\'{\i}} and Marta Molero and Nadia Abdulghani and Thaïs Comella and Rocio Sola and Montserrat Vargas and Consuleo Vilad{\'{e}}s and Anna Mart{\'{\i}} and Elena Yeregui and Anna Rull and Pilar Barrufet and Laia Arbones and Elena Chamarro and Cristina Escrig and Mireia Cair{\'{o}} and Xavier Martinez-Lacasa and Roser Font and Lizza Macorigh and Juanse Hern{\'{a}}ndez and(2022). Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study . Journal of Antimicrobial Chemotherapy. Oxford University Press ({OUP})

Ver{\'{o}}nica Rico-Caballero and Mariana Fern{\'{a}}ndez and Juan C. Hurtado and M. Angeles Marcos and Celia Cardozo and Laia Albiach and Daiana Agüero and Juan Ambrosioni and Marta Bodro and Mariana Chumbita and Lorena De la Mora and Nicole Garcia-Pouton and Ana Gonzalez-Cord{\'{o}}n and Gerard Due{\~{n}}as and Marta Hernandez-Meneses and Alexy Inciarte and Montse Laguno and Lorna Leal and Irene Macaya and Miguel J. Mart{\'{\i}}nez and Genoveva Cuesta and Fernanda Meira and Laura Morata and Pedro Puerta-Alcalde and John Rojas and Berta Torres and Pedro Castro and Jose Mu{\~{n}}oz and Josep Mensa and Jos{\'{e}} Antonio Mart{\'{\i}}nez and Gemma Sanjuan and Jordi Vila and Felipe Garc{\'{\i}}a and Carolina Garcia-Vidal and Alex Soriano and J. L. Blanco and J. Mallolas and E. Mart{\'{\i}}nez and M. Mart{\'{\i}}nez and J. M. Mir{\'{o}} and A. Moreno and A. Del Rio and M. Sol{\'{a}} and M. Torres and A. Ugarte and A. Cozar-Llad{\'{o}} and L. Linares and A. Tellez and S. Fernandez and J. M. Nicolas and D. Campubri and M. T. de Alba and M. Fernandez and E. Ferrer and B. Grau and H. Marti and M. Muelas and M. J. Pinazo and N. Rodriguez and M. Roldan and C. Subira and I. Vera and N. Williams and A. Almuedo-Riera and A. Aldea and M. Camafort and J. Calvo and A. Capdevila and F. Cardellach and I. Carbonell and E. Coloma and A. Foncillas and R. Estruch and M. Feliu and J. Fern{\'{a}}ndez-Sol{\'{a}} and I. Fuertes and C. Gabara and I. Grafia and A. Ladino and R. L{\'{o}}pez-Alfaro and A. L{\'{o}}pez-Soto and F. Masan{\'{e}}s and A. Matas and M. Navarro and J. Marco-Hern{\'{a}}ndez and L. Miguel and J. C. Milisenda and P. Moreno and J. Naval and D. Nicol{\'{a}}s and H. Oberoi and J. Padrosa and S. Prieto-Gonz{\'{a}}lez and M. Pellic{\'{e}} and J. Ribot and O. Rodr{\'{\i}}guez-N{\'{u}}nez and E. Sacanella and F. Segu{\'{\i}} and C. Sierra and A. Tom{\'{e}} and M. Torres and H. Ventosa and C. Zamora-Mart{\'{\i}}nez and M. Almela and M. Alvarez and J. Bosch and J. Costa and G. Cuesta and B. Fidalgo and J. Gonz{\`{a}}lez and F. Marco and S. Narvaez and C. Pitart and E. Rubio and A. Vergara and M. E. Valls and Y. Zboromyrska and C. Casals and M. Mosquera and E. L{\'{o}}pez and M. Tuset and(2022). Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients . Infection. Springer Science and Business Media {LLC}

Jos{\'{e}} L. Blanco and Jhon Rojas and Elisa de Lazzari and Alexy Inciarte and Mar Subirana and Pilar Callau and Mar{\'{\i}}a Martinez-Rebollar and Montserrat Laguno and Josep Mallolas and Lorena de la Mora and Berta Torres and Ana Gonzalez-Cord{\'{o}}n and Esteban Martinez(2022). Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study . Journal of Antimicrobial Chemotherapy. Oxford University Press ({OUP})

Rodrigo Alonso and Ana M. Camon and Celia Cardozo and Laia Albiach and Daiana Agüero and M. Angeles Marcos and Juan Ambrosioni and Marta Bodro and Mariana Chumbita and Lorena de la Mora and Nicole Garcia-Pouton and Gerard Due{\~{n}}as and Marta Hernandez-Meneses and Alexy Inciarte and Genoveva Cuesta and Fernanda Meira and Laura Morata and Pedro Puerta-Alcalde and Sabina Herrera and Montse Tuset and Pedro Castro and Sergio Prieto-Gonzalez and Josep Mensa and Jos{\'{e}} Antonio Mart{\'{\i}}nez and Gemma Sanjuan and J. M. Nicolas and A. del Rio and Jordi Vila and Felipe Garcia and Carolina Garcia-Vidal and Alex Soriano and J. L. Blanco and J. Mallolas and E. Mart{\'{\i}}nez and M. Mart{\'{\i}}nez and J. M. Mir{\'{o}} and A. Moreno and M. Sol{\'{a}} and A. Ugarte and Ana Gonzalez-Cord{\'{o}}n and Montse Laguno and Lorna Leal and John Rojas and Berta Torres and S. Fernandez and A. Tellez and F. Fuentes and E. Sancho and M. Ayala and D. Campubri and M. T. de Alba and M. Fernandez and E. Ferrer and B. Grau and H. Marti and M. Muelas and M. J. Pinazo and N. Rodriguez and M. Roldan and C. Subira and I. Vera and N. Williams and A. Almuedo-Riera and J. Mu{\~{n}}oz and A. Aldea and M. Camafort and J. Calvo and A. Capdevila and F. Cardellach and I. Carbonell and E. Coloma and A. Foncillas and R. Estruch and M. Feliu and J. Fern{\'{a}}ndez-Sol{\'{a}} and I. Fuertes and C. Gabara and I. Grafia and A. Ladino and R. L{\'{o}}pez-Alfaro and A. L{\'{o}}pez-Soto and I. Macaya and F. Masan{\'{e}}s and A. Matas and M. Navarro and J. Marco-Hern{\'{a}}ndez and L. Miguel and J. C. Milisenda and P. Moreno and J. Naval and D. Nicol{\'{a}}s and H. Oberoi and J. Padrosa and S. Prieto-Gonz{\'{a}}lez and M. Pellic{\'{e}} and J. Ribot and O. Rodr{\'{\i}}guez-N{\'{u}}nez and E. Sacanella and F. Segu{\'{\i}} and C. Sierra and A. Tom{\'{e}} and M. Torres and H. Ventosa and C. Zamora-Mart{\'{\i}}nez and M. Almela and M. Alvarez and J. Bosch and J. Costa and G. Cuesta and B. Fidalgo and J. Gonz{\`{a}}lez and F. Marco and S. Narvaez and C. Pitart and E. Rubio and A. Vergara and M. E. Valls and Y. Zboromyrska and E. L{\'{o}}pez and(2022). Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study . Infectious Diseases and Therapy. Springer Science and Business Media {LLC}

Rodrigo Alonso and Ana M. Camon and Celia Cardozo and Laia Albiach and Daiana Agüero and M. Angeles Marcos and Juan Ambrosioni and Marta Bodro and Mariana Chumbita and Lorena de la Mora and Nicole Garcia-Pouton and Gerard Due{\~{n}}as and Marta Hernandez-Meneses and Alexy Inciarte and Genoveva Cuesta and Fernanda Meira and Laura Morata and Pedro Puerta-Alcalde and Sabina Herrera and Montse Tuset and Pedro Castro and Sergio Prieto-Gonzalez and Josep Mensa and Jos{\'{e}} Antonio Mart{\'{\i}}nez and Gemma Sanjuan and J. M. Nicolas and A. del Rio and Jordi Vila and Felipe Garcia and Carolina Garcia-Vidal and Alex Soriano and J. L. Blanco and J. Mallolas and E. Mart{\'{\i}}nez and M. Mart{\'{\i}}nez and J. M. Mir{\'{o}} and A. Moreno and M. Sol{\'{a}} and A. Ugarte and Ana Gonzalez-Cord{\'{o}}n and Montse Laguno and Lorna Leal and John Rojas and Berta Torres and S. Fernandez and A. Tellez and F. Fuentes and E. Sancho and M. Ayala and D. Campubri and M. T. de Alba and M. Fernandez and E. Ferrer and B. Grau and H. Marti and M. Muelas and M. J. Pinazo and N. Rodriguez and M. Roldan and C. Subira and I. Vera and N. Williams and A. Almuedo-Riera and J. Mu{\~{n}}oz and A. Aldea and M. Camafort and J. Calvo and A. Capdevila and F. Cardellach and I. Carbonell and E. Coloma and A. Foncillas and R. Estruch and M. Feliu and J. Fern{\'{a}}ndez-Sol{\'{a}} and I. Fuertes and C. Gabara and I. Grafia and A. Ladino and R. L{\'{o}}pez-Alfaro and A. L{\'{o}}pez-Soto and I. Macaya and F. Masan{\'{e}}s and A. Matas and M. Navarro and J. Marco-Hern{\'{a}}ndez and L. Miguel and J. C. Milisenda and P. Moreno and J. Naval and D. Nicol{\'{a}}s and H. Oberoi and J. Padrosa and S. Prieto-Gonz{\'{a}}lez and M. Pellic{\'{e}} and J. Ribot and O. Rodr{\'{\i}}guez-N{\'{u}}nez and E. Sacanella and F. Segu{\'{\i}} and C. Sierra and A. Tom{\'{e}} and M. Torres and H. Ventosa and C. Zamora-Mart{\'{\i}}nez and M. Almela and M. Alvarez and J. Bosch and J. Costa and G. Cuesta and B. Fidalgo and J. Gonz{\`{a}}lez and F. Marco and S. Narvaez and C. Pitart and E. Rubio and A. Vergara and M. E. Valls and Y. Zboromyrska and E. L{\'{o}}pez and(2022). Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study . Infectious Diseases and Therapy. Springer Science and Business Media {LLC}

Mart&#237;nez-Rebollar M, De La Mora L, Campistol M, Cabrera B, Bagu&#233; A, De Lazzari E, Torres B, Gonz&#225;lez-Cord&#243;n A, Inciarte A, Ambrosioni J, et al.(2022). Correction to: Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study . Infectious diseases and therapy.

Alexy Inciarte(2022). C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19 . Scientific Reports. 12. (1). Springer Science and Business Media {LLC}

Lorena De La Mora and Montserrat Laguno and Elisa De Lazzari and Ainoa Ugarte and Lorna Leal and Berta Torres and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Alexy Inciarte and Juan Ambrosioni and Zoraida Escalante and Ana Rodriguez and Esteban Martinez and Jos{\'{e}} L. Blanco and Jordi Blanch and Laia Miquel and Jordi Bosch and Duncan Short and Josep Mallolas and Maria Martinez-Rebollar(2022). Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City: a Cross-Sectional Study . Sexuality Research and Social Policy. Springer Science and Business Media {LLC}

Lorena De La Mora and Montserrat Laguno and Elisa De Lazzari and Ainoa Ugarte and Lorna Leal and Berta Torres and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Alexy Inciarte and Juan Ambrosioni and Zoraida Escalante and Ana Rodriguez and Esteban Martinez and Jos{\'{e}} L. Blanco and Jordi Blanch and Laia Miquel and Jordi Bosch and Duncan Short and Josep Mallolas and Maria Martinez-Rebollar(2022). Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City: a Cross-Sectional Study . Sexuality Research and Social Policy. Springer Science and Business Media {LLC}

D Podzamczer and R Mic{\'{a}}n and J Tiraboschi and J Portilla and P Domingo and J M Llibre and E Ribera and M J Vivancos and L Morano and M Masi{\'{a}} and C G{\'{o}}mez and F Fanjul and A Payeras and A Inciarte and V Estrada and A Rivero and {\'{A}} Castro and E Bernal and D Vinuesa and H Knobel and J Troya and J Mac{\'{\i}}as and M Montero and J Sanz and A Navarro-Alcaraz and A Caicedo and G Fern{\'{a}}ndez and E Mart{\'{\i}}nez and S Moreno(2022). Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57) . Open Forum Infectious Diseases. 9. (3). Oxford University Press ({OUP})

D Podzamczer and R Mic{\'{a}}n and J Tiraboschi and J Portilla and P Domingo and J M Llibre and E Ribera and M J Vivancos and L Morano and M Masi{\'{a}} and C G{\'{o}}mez and F Fanjul and A Payeras and A Inciarte and V Estrada and A Rivero and {\'{A}} Castro and E Bernal and D Vinuesa and H Knobel and J Troya and J Mac{\'{\i}}as and M Montero and J Sanz and A Navarro-Alcaraz and A Caicedo and G Fern{\'{a}}ndez and E Mart{\'{\i}}nez and S Moreno(2022). Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57) . Open Forum Infectious Diseases. 9. (3). Oxford University Press ({OUP})

Alexy Inciarte(2022). Increasing emergency department admissions for chemsex-related intoxications in Barcelona, Spain, among people living with HIV: an observational study from 2018 to 2020 . BMC Public Health. 22. (1). Springer Science and Business Media {LLC}

Natalia A. D{\'{\i}}az and Rosa de Miguel and Fernando Agüero and Omar Sued and Jos{\'{e}} R. Arribas and Juan Ambrosioni and Juan Ambrosioni and Jos{\'{e}} L. Blanco and Lorena de la Mora and Felipe Garc{\'{\i}}a-Alcaide and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Alexis Inciarte and Montserrat Laguno and Lorna Leal and Esteban Mart{\'{\i}}nez-Chamorro and Mar{\'{\i}}a Mart{\'{\i}}nez-Rebollar and Jos{\'{e}} M. Mir{\'{o}} and Jhon F. Rojas and Berta Torres and Josep Mallolas and Laia Albiac and Daiana L. Agüero and Marta Bodro and Celia Cardozo and Mariana Chumbita and Nicol Garc{\'{\i}}a and Carolina Garc{\'{\i}}a-Vidal and Marta M. Hern{\'{a}}ndez-Meneses and Sabina Herrera and Laura Linares and Antonio Moreno and Laura Morata and Jose A. Mart{\'{\i}}nez-Mart{\'{\i}}nez and Pedro Puerta and Ver{\'{o}}nica Rico and Alex Soriano and Mikel Mart{\'{\i}}nez and Mar{\'{\i}}a del Mar Mosquera and Mar{\'{\i}}a A. Marcos and Jordi Vila and Montse Tuset and Dolors Soy and Anna Vilella and Alex Almuedo and Mar{\'{\i}}a J. Pinazo and Jos{\'{e}} Mu{\~{n}}oz and(2022). Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data . Infectious Diseases and Therapy. 11. (1). p. 1--13. Springer Science and Business Media {LLC}

Natalia A. D{\'{\i}}az and Rosa de Miguel and Fernando Agüero and Omar Sued and Jos{\'{e}} R. Arribas and Juan Ambrosioni and Juan Ambrosioni and Jos{\'{e}} L. Blanco and Lorena de la Mora and Felipe Garc{\'{\i}}a-Alcaide and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Alexis Inciarte and Montserrat Laguno and Lorna Leal and Esteban Mart{\'{\i}}nez-Chamorro and Mar{\'{\i}}a Mart{\'{\i}}nez-Rebollar and Jos{\'{e}} M. Mir{\'{o}} and Jhon F. Rojas and Berta Torres and Josep Mallolas and Laia Albiac and Daiana L. Agüero and Marta Bodro and Celia Cardozo and Mariana Chumbita and Nicol Garc{\'{\i}}a and Carolina Garc{\'{\i}}a-Vidal and Marta M. Hern{\'{a}}ndez-Meneses and Sabina Herrera and Laura Linares and Antonio Moreno and Laura Morata and Jose A. Mart{\'{\i}}nez-Mart{\'{\i}}nez and Pedro Puerta and Ver{\'{o}}nica Rico and Alex Soriano and Mikel Mart{\'{\i}}nez and Mar{\'{\i}}a del Mar Mosquera and Mar{\'{\i}}a A. Marcos and Jordi Vila and Montse Tuset and Dolors Soy and Anna Vilella and Alex Almuedo and Mar{\'{\i}}a J. Pinazo and Jos{\'{e}} Mu{\~{n}}oz and(2022). Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data . Infectious Diseases and Therapy. 11. (1). p. 1--13. Springer Science and Business Media {LLC}

Juan Ambrosioni and Jhon Rojas Li{\'{e}}vano and Leire Berrocal and Alexy Inciarte and Lorena de la Mora and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Mar{\'{\i}}a Mart{\'{\i}}nez-Rebollar and Montserrat Laguno and Berta Torres and Ainoa Ugarte and Iv{\'{a}}n Chivite and Lorna Leal and Elisa de Lazzari and Jos{\'{e}} M. Mir{\'{o}} and Jos{\'{e}} L. Blanco and Esteban Martinez and Josep Mallolas(2022). Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre . Journal of Antimicrobial Chemotherapy. Oxford University Press ({OUP})

Elisa de Lazzari and Alejandra Mart{\'{\i}}nez-Mimbrero and Iv{\'{a}}n Chivite and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Maria M. Mosquera and Montserrat Laguno and Josep Costa and Jordi Bosch and Jose L. Blanco and Miriam {\'{A}}lvarez-Martinez and Ainoa Ugarte and Alexy Inciarte and Lorena de la Mora and Berta Torres and Maria Mart{\'{\i}}nez-Rebollar and Juan Ambrosioni and Emma Fern{\'{a}}ndez and Juan Carlos Hurtado and Josep Mallolas and Jos{\'{e}} M. Mir{\'{o}} and Mar{\'{\i}}a A. Marcos and Esteban Mart{\'{\i}}nez(2022). Impact of COVID-19 epidemics on prevention and care for HIV and other sexually transmitted infections . AIDS. Publish Ahead of Print. Ovid Technologies (Wolters Kluwer Health)

M. Masi{\'{a}} and S. Padilla and G. Esta{\~{n}} and J. Portu and A. Silva and A. Rivero and A. Gonz{\'{a}}lez-Cord{\'{o}}n and L. Garc{\'{\i}}a-Fraile and O. Mart{\'{\i}}nez and E. Bernal and C. Galera and V. Boix Mart{\'{\i}}nez and J. Macias and M. Montero and D. Garc{\'{\i}}a-Rosado and M. J. Vivancos-Gallego and J. Llenas-Garc{\'{\i}}a and M. Torralba and J. A. Garc{\'{\i}}a and V. Agull{\'{o}} and M. Gonz{\'{a}}lez-Fern{\'{a}}ndez and F. Guti{\'{e}}rrez and E. Mart{\'{\i}}nez and Antonia Alcaraz-Garc{\'{\i}}a and Ana Caicedo and Alexy Inciarte and Alfredo Espinosa and Ana L{\'{o}}pez-Lirola and Concha Amador and Ana Silva and Antonio Navarro and {\'{A}}ngela Camacho and Aurora P{\'{e}}rez and Carlos Galera and Melissa Carreres and Camila Piatti and David Vinuesa and David Dalmau and D{\'{a}}cil Garc{\'{\i}}a-Rosado and Marcos Diez-Martinez and Daniel Podzamczer and Ester Saez and Esther Fag{\'{u}}ndez-Reloba and Federico Garc{\'{\i}}a and Juan Flores and Gema Garc{\'{\i}}a and Javier Garc{\'{\i}}a-Abell{\'{a}}n and Luc{\'{\i}}a Guill{\'{e}}n and Gema Navarro and Inma Gonz{\'{a}}lez-Cuello and Helena Albend{\'{\i}}n and Inmaculada Ruiz-C{\'{a}}ceres and Isabel Machuca and Ignacio Santos and Itziar Sobron and Juan Emilio Losa and Juan Luis G{\'{o}}mez-Sirvent and Jose Ramon Blanco and Juan Mac{\'{\i}}as and Juan Carlos Gainzarai and Lorena Mart{\'{\i}}nez and Josep Mallolas and Mar{\'{\i}}a del Mar Alonso-Socas and Bel{\'{e}}n Mart{\'{\i}}nez-L{\'{o}}pez and Araceli Fern{\'{a}}ndez and Mar{\'{\i}}a Jehovana Hern{\'{a}}ndez-Rodr{\'{\i}}guez and Miguel Angel Moran and Marta Navarro and Reyes Pascual and Francisco Pasquau and Pilar Callau and Joaqu{\'{\i}}n Portilla and Catalina Robledano and Jhon Rojas and Ricardo Pelazas and Sandra Cuellar and Santos Del Campo and Sonia Calzado and Santiago Moreno and Sof{\'{\i}}a Sc{\'{e}}vola and Guillemo Telenti and Zuri{\~{n}}e Ortiz and(2021). Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection . Trials. 22. (1). Springer Science and Business Media {LLC}

D Podzamczer and R Mic{\'{a}}n and J Tiraboschi and J Portilla and P Domingo and J M Llibre and E Ribera and M J Vivancos and L Morano and M Masi{\'{a}} and C G{\'{o}}mez and F Fanjul and A Payeras and A Inciarte and V Estrada and A Rivero and {\'{A}} Castro and E Bernal and D Vinuesa and H Knobel and J Troya and J Mac{\'{\i}}as and M Montero and J Sanz and A Navarro-Alcaraz and A Caicedo and G Fern{\'{a}}ndez and E Mart{\'{\i}}nez and S Moreno and(2021). Darunavir/cobicistat/emtricitabine/tenofovir alafenamide versus dolutegravir /abacavir/lamivudine in antiretroviral-naïve adults (SYMTRI): a multicenter randomized open-label study (PReEC/RIS-57) . Open Forum Infectious Diseases. Oxford University Press ({OUP})

Carolina Garcia-Vidal and Rodrigo Alonso and Ana M Camon and Celia Cardozo and Laia Albiach and Daiana Agüero and M Angeles Marcos and Juan Ambrosioni and Marta Bodro and Mariana Chumbita and Lorena de la Mora and Nicole Garcia-Pouton and Gerard Due{\~{n}}as and Marta Hernandez-Meneses and Alexy Inciarte and Genoveva Cuesta and Fernanda Meira and Laura Morata and Pedro Puerta-Alcalde and Sabina Herrera and Montse Tuset and Pedro Castro and Sergio Prieto-Gonzalez and Alex Almuedo-Riera and Josep Mensa and Jos{\'{e}} Antonio Mart{\'{\i}}nez and Gemma Sanjuan and J M Nicolas and A del Rio and Jos{\'{e}} Mu{\~{n}}oz and Jordi Vila and Felipe Garcia and Alex Soriano and J L Blanco and J Mallolas and E Mart{\'{\i}}nez and M Mart{\'{\i}}nez and J M Mir{\'{o}} and A Moreno and M Sol{\'{a}} and A Ugarte and A Gonzalez-Cord{\'{o}}n and M Laguno and L Leal and J Rojas and B Torres and S Fernandez and A Tellez and F Fuentes and M Ayala and D Campubri and M T de Alba and M Fernandez and E Ferrer and B Grau and H Marti and M Muelas and M J Pinazo and N Rodriguez and M Roldan and C Subira and I Vera and N Williams and A Almuedo-Riera and J Mu{\~{n}}oz and A Aldea and M Camafort and J Calvo and A Capdevila and F Cardellach and I Carbonell and E Coloma and A Foncillas and R Estruch and M Feliu and J Fern{\'{a}}ndez-Sol{\'{a}} and I Fuertes and C Gabara and I Grafia and A Ladino and R L{\'{o}}pez-Alfaro and A L{\'{o}}pez-Soto and I Macaya and F Masan{\'{e}}s and A Matas and M Navarro and J Marco-Hern{\'{a}}ndez and L Miguel and J C Milisenda and P Moreno and J Naval and D Nicol{\'{a}}s and H Oberoi and J Padrosa and S Prieto-Gonz{\'{a}}lez and M Pellic{\'{e}} and J Ribot and O Rodr{\'{\i}}guez-N{\'{u}}nez and E Sacanella and F Segu{\'{\i}} and C Sierra and A Tom{\'{e}} and M Torres and H Ventosa and C Zamora-Mart{\'{\i}}nez and M Almela and M Alvarez and J Bosch and J Costa and G Cuesta and B Fidalgo and J Gonz{\`{a}}lez and F Marco and S Narvaez and C Pitart and E Rubio and A Vergara and M E Valls and Y Zboromyrska and(2021). Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19 . Journal of Antimicrobial Chemotherapy. 76. (12). p. 3296--3302. Oxford University Press ({OUP})

(2021). Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial . Frontiers in Immunology.

Daniel K Nomah and Juliana Reyes-Urue{\~{n}}a and Yesika D{\'{\i}}az and Sergio Moreno and Jordi Aceiton and Andreu Bruguera and Rosa M Vivanco-Hidalgo and Josep M Llibre and Pere Domingo and Vicen{\c{c}} Falc{\'{o}} and Arkaitz Imaz and Cristina Cort{\'{e}}s and Llu{\'{\i}}s Force and Emili Letang and Ingrid Vilar{\'{o}} and Jordi Casabona and Jose M Miro and Esteve Muntada and Anna Esteve and Melchor Riera and Gemma Navarro and Hernando Knobel and Josep Mallolas and Daniel Podzamczer and Adri{\`{a}} Curran and Joaqu{\'{\i}}n Burgos and Maria Gracia Mateo and Maria del Mar Gutierrez and Javier Murillas and Francisco Homar and Jose Vicente Fern{\'{a}}ndez-Montero and Eva Gonz{\'{a}}lez and Joaquim Peraire and Francesc Vidal and Elena Leon and {\`{A}}ngels Masabeu and Amat-Joaquim Orti and David Dalmau and {\`{A}}ngels Jaen and Elisabet Deig and Elisa De Lazzari and Leire Berrocal and Guillem Fernandez and Luc{\'{\i}}a Rodr{\'{\i}}guez and Freya Gargoulas and Toni Vanrell and Jose Carlos Rubia and Josep Vil{\`{a}} and Marina Mart{\'{\i}}nez and Bibiana Morell and Maribel Tamayo and Jorge Palacio and Juan Ambrosioni and Montse Laguno and Mar{\'{\i}}a Mart{\'{\i}}nez-Rebollar and Jos{\'{e}} Luis Blanco and Felipe Garcia and Esteban Mart{\'{\i}}nez and Berta Torres and Lorena de la Mora and Alexy Inciarte and Ainoa Ugarte and Iv{\'{a}}n Chivite and Ana Gonz{\'{a}}lez-Cordon and Lorna Leal and Antoni Jou and Maria Saumoy and Ana Silva and Sofia Sc{\'{e}}vola and Jordi Navarro and Paula Suanzes and Isabel Mur and Maria {\`{A}}ngels Ribas and Antoni A Campins and Francisco Fanjul and Mar{\'{\i}}a Leyes and Mar{\'{\i}}a Pe{\~{n}}aranda and Mar{\'{\i}}a Luisa Martin and Helem Haydee Vilchez and S{\`{o}}nia Calzado and Manel Cervantes and M. Jos{\'{e}} Amengual and Marta Navarro and Antoni Payeras and Carmen Cifuentes and Aroa Villoslada and Patr{\'{\i}}cia Sorn{\'{\i}} and Marta Molero and Nadia Abdulghani and Thaïs Comella and Rocio Sola and Montserrat Vargas and Consuleo Vilad{\'{e}}s and Anna Mart{\'{\i}} and Pilar Barrufet and Laia Arbones and Elena Chamarro and Mireia Cair{\'{o}} and Xavier Martinez-Lacas and Roser Font and Lizza Macorigh(2021). Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study . The Lancet HIV. 8. (11). p. e701--e710. Elsevier {BV}

de Lazzari E, Gonzalez-Cordon A, Inciarte A, Ugarte A, de la Mora L, Martinez-Rebollar M, Laguno M, Ambrosioni J, Torres B, Mallolas J, et al.(2021). Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort . The Journal of antimicrobial chemotherapy.

Juan Berenguer and Alberto M Borobia and Pablo Ryan and Jes{\'{u}}s Rodr{\'{\i}}guez-Ba{\~{n}}o and Jose M Bell{\'{o}}n and Inmaculada Jarr{\'{\i}}n and Jordi Carratal{\`{a}} and Jer{\'{o}}nimo Pach{\'{o}}n and Antonio J Carcas and Mar{\'{\i}}a Yllescas and Jos{\'{e}} R Arribas(2021). Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score . Thorax. 76. (9). p. 920--929. {BMJ}

Alexy Inciarte and Celia Cardozo and Mariana Chumbita and Pau Alcubilla and Berta Torres and Ana Gonz{\'{a}}lez Cord{\'{o}}n and Veronica Rico and Daiana Aguero and Nicole Garc{\'{\i}}a-Pouton and Marta Hern{\'{a}}ndez-Meneses and Laia Albiach and Fernanda Meira and Lorena De la Mora and laura Linares and Pedro Puerta-Alcalde and Irene Macaya and Josep Mensa and Montse Laguno and Juan Ambrosioni and Angela Ramos and Laura Morata and Marta Bodro and Estela Moreno-Garc{\'{\i}}a and Antonio Moreno and Montse Sola and Jhon Rojas and Lorna Leal and Manuel Torres and Carolina Garcia-Vidal and Jose Antonio Mart{\'{\i}}nez and Isam Alobid and Alex Soriano and Felipe Garcia(2021). Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study . BMJ Open. 11. (8). p. e040775. {BMJ}

Alexy Inciarte, Celia Cardozo, Mariana Chumbita, Pau Alcubilla, Berta Torres, Ana Gonz&#225;lez Cord&#243;n, Veronica Rico, Daiana Aguero, Nicole Garc&#237;a-Pouton, Marta Hern&#225;ndez-Meneses, et al. (2021). Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study . BMJ Open.

Montserrat Laguno and Mar{\'{\i}}a Mart{\'{\i}}nez-Rebollar and Martina Casanova and Elisa de Lazzari and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Berta Torres and Alexy Inciarte and Lorena de la Mora and Ainoa Ugarte and Juan Ambrosioni and Jos{\'{e}} Lu{\'{\i}}s Blanco and Esteban Mart{\'{\i}}nez and Josep Mallolas(2021). Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients . Clinical Microbiology and Infection. Elsevier {BV}

(2021). Experience with the use of siltuximab in patients with SARS-CoV-2 infection . Revista Española de Quimioterapia.

Estela Moreno-Garc{\'{\i}}a and Ver{\'{o}}nica Rico and Laia Albiach and Daiana Agüero and Juan Ambrosioni and Marta Bodro and Celia Cardozo and Mariana Chumbita and Lorena De la Mora and Nicole Garc{\'{\i}}a-Pouton and Carolina Garcia-Vidal and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Marta Hern{\'{a}}ndez-Meneses and Alexy Inciarte and Montse Laguno and Lorna Leal and Laura Linares and Irene Macaya and Fernanda Meira and Josep Mensa and Antonio Moreno and Laura Morata and Pedro Puerta-Alcalde and Jhon Rojas and Montse Sol{\'{a}} and Berta Torres and Manuel Torres and Adri{\`{a}} Tom{\'{e}} and Montse Tuset and Pedro Castro and Sara Fern{\'{a}}ndez and Josep Maria Nicol{\'{a}}s and Alex Almuedo-Riera and Jose Mu{\~{n}}oz and Mariana Fernandez-Pittol and Maria Angeles Marcos and Dolors Soy and Jos{\'{e}} Antonio Mart{\'{\i}}nez and Felipe Garc{\'{\i}}a and Alex Soriano and(2021). Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection . Revista Española de Quimioterapia. 34. (3). p. 238--244. Sociedad Espanola de Quimioterapia

Montserrat Laguno and Ainoa Ugarte and Mar{\'{\i}}a Martinez-Rebollar and Yeray Sobrino and Guillermo Font and Elisa de Lazzari and Lorena de la Mora and Berta Torres and Iv{\'{a}}n Chivite and Josep Riera and Juan Ambrosioni and Alexy Inciarte and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Jhon Rojas and Encarna Cord{\'{o}}n and Jos{\'{e}} Luis Blanco and Esteban Mart{\'{\i}}nez and Josep Mallolas(2021). Experiencia de un programa de profilaxis preexposición en una unidad de virus de la inmunodeficiencia humana hospitalaria. Descripción del perfil basal del usuario e identificación de oportunidades de mejora . Enfermedades Infecciosas y Microbiología Clínica. Elsevier {BV}

Juan Ambrosioni and Jos{\'{e}} Luis Blanco and Juliana M Reyes-Urue{\~{n}}a and Mary-Ann Davies and Omar Sued and Maria Angeles Marcos and Esteban Mart{\'{\i}}nez and Silvia Bertagnolio and Jose Alcam{\'{\i}} and Jose M Miro and Juan Ambrosioni and Jose L. Blanco and Lorena de la Mora and Felipe Garcia-Alcaide and Ana Gonz{\'{a}}lez-Cord{\'{o}}n and Alexis Inciarte and Montserrat Laguno and Lorna Leal and Esteban Mart{\'{\i}}nez-Chamorro and Mar{\'{\i}}a Mart{\'{\i}}nez-Rebollar and Jos{\'{e}} M Mir{\'{o}} and Jhon F. Rojas and Berta Torres and Josep Mallolas and Laia Albiac and Daiana L. Agöero and Marta Bodro and Celia Cardozo and Mariana Chumbita and Nicol Garc{\'{\i}}a and Carolina Garc{\'{\i}}a-Vidal and Marta M. Hern{\'{a}}ndez-Meneses and Sabina Herrera and Laura Linares and Antonio Moreno and Laura Morata and Jose A. Mart{\'{\i}}nez-Mart{\'{\i}}nez and Pedro Puerta and Ver{\'{o}}nica Rico and Alex Soriano and Mikel Mart{\'{\i}}nez and Mar{\'{\i}}a del Mar Mosquera and Maria A. Marcos and Jordi Vila and Montse Tuset and Dolors Soy and Anna Vilella and Alex Almuedo and Mar{\'{\i}}a J. Pinazo and Jose Mu{\~{n}}oz(2021). Overview of SARS-CoV-2 infection in adults living with HIV . The Lancet HIV. 8. (5). p. e294--e305. Elsevier {BV}

Mart&#237;nez-Rebollar M, De La Mora L, Campistol M, Cabrera B, Bagu&#233; A, De Lazzari E, Torres B, Gonz&#225;lez-Cord&#243;n A, Inciarte A, Ambrosioni J, et al.(2021). Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study . Infectious diseases and therapy.

(2021). Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study . The Lancet. Infectious diseases.

(2021). Effective treatment of Lymphogranuloma venereum proctitis with Azithromycin . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

(2021). Acute poisonings in patients with human immunodeficiency virus infection: factors related to need for admission. Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias.

(2020). Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome . International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

(2020). Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results . The New England journal of medicine.

(2020). High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients . EBioMedicine.

(2020). Network meta-analysis of post-exposure prophylaxis randomized clinical trials . HIV medicine.

(2020). Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study . AIDS (London, England).

(2020). Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain . Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

(2020). Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study . Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

(2020). Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study . Annals of internal medicine.

(2020). Smell and Taste Dysfunction in COVID-19 Is Associated With Younger Age in Ambulatory Settings: A Multicenter Cross-Sectional Study . Journal of investigational allergology & clinical immunology.

(2020). About "Executive summary of the GeSIDA consensus document on control and monitoring of HIV-infected patients" . Enfermedades infecciosas y microbiologia clinica.

A Inciarte, L Leal, L Masfarre, E Gonzalez, V Diaz‐Brito, C Lucero, J Garcia‐Pindado, A Le&#243;n, F Garc&#237;a (2020). Post‐exposure prophylaxis for HIV infection in sexual assault victims . HIV Medicine.

Inciarte, A., Leal, L., Masfarre, L., Gonzalez, E., Diaz-Brito, V., Lucero, C., Garcia-Pindado, J., Le&#243;n, A., Garc&#237;a, F., Manzardo, C., et al.(2020). Post-exposure prophylaxis for HIV infection in sexual assault victims . HIV Medicine. 21. (1). p. 43-52.

De Lazzari, E., Lonca, M., Rojas, J., Gonzalez-Cordon, A., Blanch, J., Inciarte, A., Tricas, A., Rodriguez, A., Martinez-Rebollar, M., Laguno, M., et al.(2019). A 24-week pilot study of dual maintenance therapy with raltegravir and lamivudine . AIDS. 33. (12). p. 1891-1896.

Perello, R., Vergara, A., Monclus, E., Jimenez, S., Montero, M., Saubi, N., Moreno, A., Eto, Y., Inciarte, A., Mallolas, J., et al.(2019). Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy . BMC Infectious Diseases. 19. (1).

Blanco, J.L., Rojas, J., Paredes, R., Negredo, E., Mallolas, J., Casadella, M., Clotet, B., Gatell, J.M., de Lazzari, E., Martinez, E., et al.(2018). Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: A planned 24 week analysis of the DOLAM randomized clinical trial . Journal of Antimicrobial Chemotherapy. 73. (7). p. 1965-1971.

Medrano, L.M., Jim&#233;nez, J.L., Jim&#233;nez-Sousa, M.A., Fern&#225;ndez-Rod&#237;guez, A., Guti&#233;rrez-Rivas, M., Bell&#243;n, J.M., Blanco, J.R., Inciarte, A., Mu&#241;oz-Fern&#225;ndez, M.&#193;., Resino, S.(2017). IL7RA polymorphisms are not associated with AIDS progression . European Journal of Clinical Investigation. 47. (10). p. 719-727.

Inciarte, A., Leal, L., Gonz&#225;lez, E., Le&#243;n, A., Lucero, C., Mallolas, J., Torres, B., Laguno, M., Rojas, J., Mart&#237;nez-Rebollar, M., et al.(2017). Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis . Journal of Antimicrobial Chemotherapy. 72. (10). p. 2857-2861.

Leal L, Le&#243;n A, Torres B, Inciarte A, Lucero C, Mallolas J, Laguno M, Mart&#237;nez-Rebollar M, Gonz&#225;lez-Cord&#243;n A, Manzardo C, et al.(2016). A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection . The Journal of antimicrobial chemotherapy.

Leal, L., Le&#243;n, A., Torres, B., Inciarte, A., Lucero, C., Mallolas, J., Laguno, M., Mart&#237;nez-Rebollar, M., Gonz&#225;lez-Cord&#243;n, A., Manzardo, C., et al.(2016). A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection . Journal of Antimicrobial Chemotherapy. 71. (7). p. 1982-1986.

Bosch, X., Moncl&#250;s, E., Inciarte, A., Moreno, P., Jord&#225;n, A., L&#243;pez-Soto, A.(2016). Factors Associated with Hospitalization among Emergency Department Patients Referred for Quick Investigation of Iron-Deficiency Anemia . Journal of Emergency Medicine. 50. (3). p. 394-402.e1.

Leal, L., Torres, B., Le&#243;n, A., Lucero, C., Inciarte, A., Diaz-Brito, V., De Lazzari, E., Gatell, J.M., Garc&#237;a, F.(2016). Predictive Factors for HIV Seroconversion among Individuals Attending a Specialized Center after an HIV Risk Exposure: A Case-Control Study . AIDS Research and Human Retroviruses. 32. (10-11). p. 1016-1021.

Le&#243;n, A., Leal, L., Torres, B., Lucero, C., Inciarte, A., Arnedo, M., Plana, M., Vila, J., Gatell, J.M., Garc&#237;a, F.(2015). Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patients . AIDS. 29. (6). p. 675-681.

Andr&#233;s, C., Plana, M., Guardo, A.C., Alvarez-Fern&#225;ndez, C., Climent, N., Gallart, T., Le&#243;n, A., Clotet, B., Autran, B., Chomont, N., et al.(2015). HIV-1 reservoir dynamics after vaccination and antiretroviral therapy interruption are associated with dendritic cell vaccine-induced T cell responses . Journal of Virology. 89. (18). p. 9189-9199.

Doti, P., Castro, P., Mart&#237;nez, M.J., Zboromyrska, Y., Aldasoro, E., Inciarte, A., Requena, A., Milisenda, J., Fern&#225;ndez, S., Nicol&#225;s, J.M., et al.(2013). A case of Japanese encephalitis in a 20 year-old Spanish sportsman, February 2013 . Eurosurveillance. 18. (35).

Moreno-Garc&#237;a E, Rico V, Albiach L, Ag&#252;ero D, Ambrosioni J, Bodro M, Cardozo C, Chumbita M, De la Mora L, Garc&#237;a-Pouton N, et al.(2020). Tocilizumab is associated with reduced risk of ICU admission and mortality in patients with SARS-CoV-2 infection .